Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interethnic differences in drug response: the contribution of genetic variability in beta adrenergic receptor and cytochrome P4502C9.

Clinical pharmacology and therapeutics - 1 Aug 2007

Muszkat M

Abstract excerpt

Ethnic differences in drug response have been extensively reported, and ethnicity has been suggested to be useful clinically as a predictor of drug response. Genetic polymorphisms in the genes encoding beta(1) adrenergic receptor (AR) and beta(2) AR, targets of beta AR antagonists, and in cytochrome P4502C9, the enzyme involved in warfarin metabolism, have the potential to explain some of the observed ethnic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Asian People
Share to Black People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Share to Receptors, Adrenergic

Share to White People

Source

Identifiers

PMID: 17329986
DOI: 10.1038/sj.clpt.6100142

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interethnic differences in drug response: the contribution of genetic variability in beta adrenergic receptor and cytochrome P4502C9.PMID 17329986Read ↗

Cytochrome P450 variations in different ethnic populations.Semantic proximity Read ↗

[Ethnicity in pharmacogenetics].Semantic proximity Read ↗

Precision medicine: does ethnicity information complement genotype-based prescribing decisions?Semantic proximity Read ↗

Race, ethnicity, ancestry, and pharmacogenetics.Semantic proximity Read ↗

[Pharmacogenomics: inter-ethnic and intra-ethnic differences in pharmacokinetic and pharmacodynamic profiles of clinically relevant drugs].Semantic proximity Read ↗

The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure.Semantic proximity Read ↗

Ethnicity and pharmacogenetics.Semantic proximity Read ↗

Ethnic and genetic determinants of cardiovascular response to the selective alpha 2-adrenoceptor agonist dexmedetomidine.Semantic proximity Read ↗

Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1).Semantic proximity Read ↗

Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in IraqSemantic proximity Read ↗

CYP2C9 polymorphism: impact on tolbutamide pharmacokinetics and response.Semantic proximity Read ↗

Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.